244 related articles for article (PubMed ID: 23283371)
1. Intraosseous injection of rhBMP-2/calcium phosphate matrix improves bone structure and strength in the proximal aspect of the femur in chronic ovariectomized nonhuman primates.
Seeherman HJ; Li XJ; Smith E; Parkington J; Li R; Wozney JM
J Bone Joint Surg Am; 2013 Jan; 95(1):36-47. PubMed ID: 23283371
[TBL] [Abstract][Full Text] [Related]
2. rhBMP-2 induces transient bone resorption followed by bone formation in a nonhuman primate core-defect model.
Seeherman HJ; Li XJ; Bouxsein ML; Wozney JM
J Bone Joint Surg Am; 2010 Feb; 92(2):411-26. PubMed ID: 20124069
[TBL] [Abstract][Full Text] [Related]
3. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations.
Seeherman H; Li R; Bouxsein M; Kim H; Li XJ; Smith-Adaline EA; Aiolova M; Wozney JM
J Bone Joint Surg Am; 2006 Jan; 88(1):144-60. PubMed ID: 16391260
[TBL] [Abstract][Full Text] [Related]
4. rhBMP-2/calcium phosphate matrix induces bone formation while limiting transient bone resorption in a nonhuman primate core defect model.
Seeherman HJ; Li XJ; Smith E; Wozney JM
J Bone Joint Surg Am; 2012 Oct; 94(19):1765-76. PubMed ID: 23032587
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of recombinant human bone morphogenetic protein-2/calcium phosphate matrix for closed tibial diaphyseal fracture: a double-blind, randomized, controlled phase-II/III trial.
Lyon T; Scheele W; Bhandari M; Koval KJ; Sanchez EG; Christensen J; Valentin A; Huard F
J Bone Joint Surg Am; 2013 Dec; 95(23):2088-96. PubMed ID: 24306695
[TBL] [Abstract][Full Text] [Related]
6. Teriparatide [PTH(1-34)] strengthens the proximal femur of ovariectomized nonhuman primates despite increasing porosity.
Sato M; Westmore M; Ma YL; Schmidt A; Zeng QQ; Glass EV; Vahle J; Brommage R; Jerome CP; Turner CH
J Bone Miner Res; 2004 Apr; 19(4):623-9. PubMed ID: 15005850
[TBL] [Abstract][Full Text] [Related]
7. A single percutaneous injection of recombinant human bone morphogenetic protein-2 accelerates fracture repair.
Einhorn TA; Majeska RJ; Mohaideen A; Kagel EM; Bouxsein ML; Turek TJ; Wozney JM
J Bone Joint Surg Am; 2003 Aug; 85(8):1425-35. PubMed ID: 12925621
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human bone morphogenetic protein-2 delivered in an injectable calcium phosphate paste accelerates osteotomy-site healing in a nonhuman primate model.
Seeherman HJ; Bouxsein M; Kim H; Li R; Li XJ; Aiolova M; Wozney JM
J Bone Joint Surg Am; 2004 Sep; 86(9):1961-72. PubMed ID: 15342759
[TBL] [Abstract][Full Text] [Related]
9. The effect of recombinant human bone morphogenetic protein-2 on femoral reconstruction with an intercalary allograft in a dog model.
Pluhar GE; Manley PA; Heiner JP; Vanderby R; Seeherman HJ; Markel MD
J Orthop Res; 2001 Mar; 19(2):308-17. PubMed ID: 11347706
[TBL] [Abstract][Full Text] [Related]
10. Systemic Administration of Sclerostin Antibody Enhances Bone Morphogenetic Protein-Induced Femoral Defect Repair in a Rat Model.
Tinsley BA; Dukas A; Pensak MJ; Adams DJ; Tang AH; Ominsky MS; Ke HZ; Lieberman JR
J Bone Joint Surg Am; 2015 Nov; 97(22):1852-9. PubMed ID: 26582615
[TBL] [Abstract][Full Text] [Related]
11. Direct percutaneous gene delivery to enhance healing of segmental bone defects.
Betz OB; Betz VM; Nazarian A; Pilapil CG; Vrahas MS; Bouxsein ML; Gerstenfeld LC; Einhorn TA; Evans CH
J Bone Joint Surg Am; 2006 Feb; 88(2):355-65. PubMed ID: 16452748
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous injection of recombinant human bone morphogenetic protein-2 in a calcium phosphate paste accelerates healing of a canine tibial osteotomy.
Edwards RB; Seeherman HJ; Bogdanske JJ; Devitt J; Vanderby R; Markel MD
J Bone Joint Surg Am; 2004 Jul; 86(7):1425-38. PubMed ID: 15252089
[TBL] [Abstract][Full Text] [Related]
13. rhBMP-2 delivered in a calcium phosphate cement accelerates bridging of critical-sized defects in rabbit radii.
Seeherman HJ; Azari K; Bidic S; Rogers L; Li XJ; Hollinger JO; Wozney JM
J Bone Joint Surg Am; 2006 Jul; 88(7):1553-65. PubMed ID: 16818982
[TBL] [Abstract][Full Text] [Related]
14. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats.
Lieberman JR; Daluiski A; Stevenson S; Wu L; McAllister P; Lee YP; Kabo JM; Finerman GA; Berk AJ; Witte ON
J Bone Joint Surg Am; 1999 Jul; 81(7):905-17. PubMed ID: 10428121
[TBL] [Abstract][Full Text] [Related]
15. Histological changes of an injectable rhBMP-2/calcium phosphate cement in vertebroplasty of rhesus monkey.
Bai B; Yin Z; Xu Q; Lew M; Chen Y; Ye J; Wu J; Chen D; Zeng Y
Spine (Phila Pa 1976); 2009 Aug; 34(18):1887-92. PubMed ID: 19680096
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between bone microarchitecture and strength in ovariectomized monkeys treated with teriparatide.
Chen P; Jerome CP; Burr DB; Turner CH; Ma YL; Rana A; Sato M
J Bone Miner Res; 2007 Jun; 22(6):841-8. PubMed ID: 17352652
[TBL] [Abstract][Full Text] [Related]
17. Ability of recombinant human bone morphogenetic protein 2 to enhance bone healing in the presence of tobramycin: evaluation in a rat segmental defect model.
Glatt V; Kwong FN; Park K; Parry N; Griffin D; Vrahas M; Evans CH; Harris M
J Orthop Trauma; 2009; 23(10):693-701. PubMed ID: 19858977
[TBL] [Abstract][Full Text] [Related]
18. Nanohydroxyapatite Based Ceramic Carrier Promotes Bone Formation in a Femoral Neck Canal Defect in Osteoporotic Rats.
Qayoom I; Teotia AK; Kumar A
Biomacromolecules; 2020 Feb; 21(2):328-337. PubMed ID: 31637919
[TBL] [Abstract][Full Text] [Related]
19. Additive enhancement of implant fixation following combined treatment with rhTGF-beta2 and rhBMP-2 in a canine model.
Sumner DR; Turner TM; Urban RM; Virdi AS; Inoue N
J Bone Joint Surg Am; 2006 Apr; 88(4):806-17. PubMed ID: 16595471
[TBL] [Abstract][Full Text] [Related]
20. Augmentation of femoral neck fracture fixation with an injectable calcium-phosphate bone mineral cement.
Stankewich CJ; Swiontkowski MF; Tencer AF; Yetkinler DN; Poser RD
J Orthop Res; 1996 Sep; 14(5):786-93. PubMed ID: 8893773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
